KAZIA THERAPEUTICS LTD

Historical 13F Holders

Symbol
KZIA
CUSIP
48669G105
All holders as of
Q3 2024
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 48669G105 since 12/18/2024, newest first.

Filer % of Class Filed
Dauntless Investment Group, LLC 13G/A Amendment 4 5.4% 10/2/2026
Event 9/25/2026
Chernett Jorey 13G/A Amendment 4 19.6% 8/19/2026
Event 8/5/2026
Chernett Jorey 13G/A Amendment 3 18.5% 5/27/2026
Event 5/26/2026
Chernett Jorey 13G/A Amendment 2 13.9% 3/31/2026
Event 3/24/2026
Alumni Capital LP 13G/A Amendment 5
0% 3/30/2026
Event 1/30/2026
Chernett Jorey 13G/A Amendment 1 12.5% 2/20/2026
Event 2/18/2026
Dauntless Investment Group, LLC 13G/A Amendment 3 0% 2/12/2026
Event 12/31/2025
Dauntless Investment Group, LLC 13G/A Amendment 2 9.9% 11/14/2025
Event 9/30/2025
Alumni Capital LP 13G/A Amendment 4
10.0% 9/12/2025
Event 7/31/2025
Dauntless Investment Group, LLC 13G/A Amendment 1 8.4% 8/5/2025
Event 6/30/2025
Dauntless Investment Group, LLC 13G 5.9% 6/13/2025
Event 6/11/2025
Chernett Jorey 13G 9.9% 6/12/2025
Event 6/11/2025
Alumni Capital LP 13G/A Amendment 1
10.0% 3/19/2025
Event 3/10/2025
Alumni Capital LP 13G
10.0% 1/16/2025
Event 1/10/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q3 21 2.17 M $932 k
2024 Q2 15 593 k $135 k
2024 Q1 15 767 k $238 k
2023 Q4 21 5.09 M $2.24 M
2023 Q3 11 237 k $236 k
2023 Q2 10 284 k $328 k
2023 Q1 9 271 k $279 k
2022 Q4 11 427 k $262 k
2022 Q3 11 481 k $527 k
2022 Q2 14 294 k $1.24 M
2022 Q1 13 376 k $2.90 M
2021 Q4 15 526 k $4.44 M
2021 Q3 20 540 k $5.03 M
2021 Q2 18 536 k $4.35 M
2021 Q1 18 467 k $4.60 M
2020 Q4 18 562 k $4.12 M
2020 Q3 14 992 k $2.31 M
2020 Q2 11 860 k $723 k
2020 Q1 11 811 k $472 k
2019 Q4 11 250 k $671 k
2019 Q3 11 254 k $568 k
2019 Q2 10 227 k $324 k
2019 Q1 8 205 k $365 k
2018 Q4 9 217 k $293 k
2018 Q3 12 221 k $400 k
2018 Q2 9 111 k $1.75 M
2018 Q1 8 94.7 k $531 k
2017 Q4 7 451 k $269 k